Recent Articles from Business Wire

Adler & Stachenfeld ("A&S"), a leading law firm focused on all facets of commercial real estate law, today announced that it has relocated its headquarters to a 40,000-square-foot space comprising the entire 12th floor of 1301 Avenue of the Americas.

BrightonOne today announced that Dana-Farber Cancer Institute, a world leader in adult and pediatric cancer treatment and research, has joined the provider network of US Family Health Plan (USFHP) of Southern New England, expanding access to exceptional cancer care for beneficiaries across the region.

Mary Kay Inc., the iconic beauty giant announced today the launch of the K-Beauty Texture Edit, a special-edition skin care collection available while supplies last. The collection builds on the momentum of the company's largest consumer-facing global brand platform, Beauty Is More Beautiful Shared™ which launched in September.

Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, today announced publication of new peer-reviewed research in npj Parkinson's Disease, a Nature Portfolio journal, demonstrating that its skin-based α-synuclein seed amplification assay (skin SAA) can differentiate multiple system atrophy (MSA) from neuronal synuclein diseases (NSD), including Parkinson's disease (PD) and dementia with Lewy bodies (DLB), representing an important step toward expanding access to seed amplification-based biomarker testing for neurodegenerative disease.

Elevance Health (NYSE: ELV) will release third quarter 2026 financial results on October 21, 2026 at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:

Energy Capital Partners (“ECP”), a leading investment firm across energy transition infrastructure and part of Bridgepoint Group (LSE: BPT), today announced the successful closing of a single-asset continuation vehicle with $834 million in capital commitments for Next Wave Energy Partners, LP ("Next Wave"). The continuation vehicle is anchored by GCM Grosvenor, Phoenix Insurance, Ardian, StepStone and North Hudson Resource Partners, alongside new and returning limited partners and provides ECP IV investors with the opportunity to fully monetize their stake in Next Wave while enabling new investors to invest in the company. As part of this transaction, ECP will reinvest its proceeds into the continuation vehicle, reflecting its continued conviction in Next Wave.

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced that the U.S. Food and Drug Administration (FDA) has approved an expanded range of Motiva SmoothSilk® Round and Motiva SmoothSilk Ergonomix® breast implants for use in the United States.

Powerus Corporation (Nasdaq: PUSA), a U.S. defense technology company focused on autonomous and unmanned systems, today announced that it has received an order of $82 million for counter-unmanned aerial systems, placed under an existing U.S. government indefinite-delivery/indefinite-quantity (IDIQ) contract. It is the second order placed under that contract. Deliveries are expected over the next several quarters.

Perfect Corp. (NYSE: PERF), the leading AI and AR beauty and fashion technology company, brought together leaders across beauty, fashion, retail and technology at its 8th Global Beauty & Fashion Tech Forum to explore how AI is moving beyond experimentation and delivering real-world business impact.

Teledyne Imaging Sensors (TIS), a part of Teledyne Technologies Incorporated and a global leader in advanced infrared imaging solutions for space and defense applications, today announced a milestone in support of the U.S. Space Force and Space Development Agency’s (SDA) Proliferated Warfighter Space Architecture (PWSA). Through its participation in SDA Tracking Layer programs, Teledyne has delivered more than 1.3 billion infrared detector pixels for missile warning and missile tracking missions supporting national defense objectives.

Vyome Holdings, Inc. (Nasdaq: HIND) (“Vyome”), a clinical-stage biopharmaceutical company focused on immuno-inflammatory and rare disease conditions, today announced that the United States Patent and Trademark Office (“USPTO”) has issued a Notice of Allowance for U.S. Patent Application No. 17/787,303, titled “Formulations and Method for Treatment of Inflammatory Diseases.”

Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced that the Company will release financial results for the third quarter of 2026 on Tuesday, November 10, 2026, after the market closes. Members of the Company’s management team plan to host a live webcast at 4:30 p.m. Eastern Time on that day to discuss the financial results as well as management’s outlook for the business. The conference call will be webcast live at http://ir.evolvtechnology.com.

ANDRA (Adaptable Network Designed for Regulated Assets) today announced an institutional issuer-sponsored tokenization platform for ETF issuers, supporting tokenized ETF workflows alongside the settlement, custody, and service-provider infrastructure they already use.

ZoomInfo (NASDAQ: GTM), the all-in-one AI GTM platform, today announced that it has been positioned as a Leader in its first appearance in the 2026 IDC MarketScape for Worldwide Unified Revenue Orchestration Platforms (Doc. #US54121526, September 2026).

Optimum, a leading provider of fiber internet, mobile, and TV services, today announced a week-long community initiative across Lake Charles – including continued enhancements to its network – as well as support for the people, organizations and neighborhoods that make the community strong.

Niobrara Capital Partners (“Niobrara”), a New York-based private equity firm focused on investing in business-to-business technology and tech-enabled services companies, today announced the successful final close of Niobrara Founders Fund L.P. (together with its parallel funds, the “Fund”) with total committed capital of over $1.1 billion, and over $1.5 billion including related co-investment vehicles.

Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter "Shionogi") announced that its Board of Directors, at a meeting held on October 5, 2026, approved Shionogi entering into an agreement to acquire IntraBio Inc. (Head Office: Austin, TX; hereinafter “IntraBio”), a biopharmaceutical company developing and commercializing therapies for neurodegenerative diseases. Pursuant to the agreement, which was signed by the parties today, IntraBio would become a wholly owned subsidiary of Shionogi Inc., a New Jersey-based subsidiary of Shionogi. The proposed transaction, which is subject to customary closing conditions, would add AQNEURSA® (levacetylleucine) and IntraBio’s capabilities in the rare disease area to Shionogi’s growing portfolio.

GE HealthCare (Nasdaq: GEHC) today announced a definitive agreement to acquire SOFIE Biosciences, a leading U.S.-based CMO for PET radiopharmaceuticals, from Trilantic North America, for a purchase price of $945 million paid in cash. The transaction is expected to close in the first half of 2027, subject to closing conditions, including regulatory approvals, at which time SOFIE Biosciences will become part of GE HealthCare’s PDx segment.

Newbridge Securities Corporation (“Newbridge”), announced the appointment of Lou Basenese as Managing Director, Investment Banking and Chief Market Strategist. Basenese will work through Newbridge’s Investment Banking Department and will be based out of the Black River Management Ltd. branch office in Morristown, New Jersey.

Travel + Leisure Co. is advancing the next phase of Sports Illustrated Resorts through an expanded partnership with Wyndham Hotels & Resorts that establishes the framework to build, operate and scale hotels under Sports Illustrated Resorts as a complementary, yet differentiated, hospitality and mixed-use development platform.

Visa (NYSE: V), a global leader in digital payments, is building a fan-first pro football platform designed to connect more directly with fans, teams, communities, and culture. The company is announcing new partnerships with the Los Angeles Rams, Los Angeles Chargers, Kansas City Chiefs, Washington Commanders, Dallas Cowboys, Houston Texans, and Philadelphia Eagles, and long-term renewals with the San Francisco 49ers, New England Patriots, Buffalo Bills, and Pittsburgh Steelers, alongside current partnerships with the Chicago Bears and Baltimore Ravens.

IMSAR LLC (“IMSAR” or the “Company”), a leading developer and manufacturer of low size, weight and power (“SWaP”) synthetic aperture radar (“SAR”) payloads and mission software for unmanned and manned aircraft, today announced the completion of a strategic investment from OceanSound Partners (“OceanSound”), a private equity firm that invests in technology and technology-enabled services companies serving aerospace, defense, government, and highly regulated end markets. Ryan Smith, Founder and Chief Executive Officer of IMSAR, will continue to lead the Company and has retained significant ownership interest alongside the management team.

Comtech Telecommunications Corp. (NASDAQ: CMTL) (“Comtech” or the “Company”), a global communications technology leader, today announced that its Board of Directors (the “Board”) has appointed Christopher D. Maloney as an independent director, effective October 1, 2026. Following Mr. Maloney's appointment, the Board will consist of seven directors.

Business Ingenuity, Inc. today announced the availability of Edgy, an AI agent educated using Natural Synergy: From Natural Mystery to Mastery, co-authored by co-founder Charles Follett and Ray Scott and available on Amazon. Edgy analyzes an organization through its public footprint and its own people, then tells executives which Operating State the organization occupies, which direction it is being driven, and what adjustments would improve its performance.

Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the appointment of Mike Noonen to its Board of Directors, effective October 9, 2026. Mr. Noonen will serve on the Board's Compensation Committee and Technology Committee. With his appointment, the Board expands to seven directors.

Iambic Therapeutics, Inc. (Iambic), a clinical-stage life science and technology company developing novel medicines using its AI-driven platform, today announced the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) to initiate a Phase 1/2 clinical trial evaluating IAM217, a brain-penetrant, differentiated inhibitor of KIF18A for the potential treatment of triple-negative breast cancer, ovarian cancer, and other solid tumor indications with chromosomal instability (CIN). In a preclinical brain metastasis model, IAM217 produced approximately 90% regression of established intracranial tumors.

Seven Hills Realty Trust (Nasdaq: SEVN) today provided a business update, including announcing the closing of two new first mortgage loan investments totaling $98.0 million secured by multifamily and mixed-use properties, the repayment of two loans resulting in proceeds of $68.0 million, and the reduction in its office exposure to approximately 13% of its portfolio as of September 30, 2026 based on outstanding principal balances.

Vasomune Therapeutics, Inc. ("Vasomune"), a clinical-stage biopharmaceutical company developing therapies that target endotheliopathy to prevent and reverse vascular leak, today announced that it is receiving advisory services and research and development funding of up to $280,347, through the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP).

Silvio Tavares, President and CEO of VantageScore, will participate in three investor conferences in the fourth quarter of 2026.

Alliance Foundation Trials, LLC (AFT), a national leader in conducting innovative, practice-changing cancer clinical trials, and Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the launch of AFT-70 NAVIGATE, a randomized phase III trial evaluating a novel molecular residual disease (MRD)-guided treatment strategy for patients with intermediate and high-risk ER-positive/HER2-negative early breast cancer. The trial is sponsored and led by AFT, with collaboration and co-funding from Natera and Genentech, a member of the Roche Group.

Highwater (the “Company”), a leading provider of naval services to the U.S., Australian, and Allied navies, today announced the appointments of Dave Whitcomb as Chief Operating Officer and Scott McMurtry as Chief Financial Officer of Highwater, and Andy Davis as Chief Executive Officer of Highwater Australia. All three executives will report to Steve Zogas, Highwater’s global CEO. Highwater is a portfolio company of Arlington Capital Partners, a Washington, D.C.-area private investment firm specializing in defense and government-regulated industries.

Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with neurodegenerative disorders, today announced full enrollment of the planned 120 participants in the Company’s Phase 2/3 ALSTARS Trial (NCT07161999) evaluating COYA 302, Coya’s combination of proprietary low-dose IL-2 and CTLA-4 Ig, for the potential treatment of amyotrophic lateral sclerosis (ALS). Additional participants already engaged in active screening will be allowed to enroll in the trial if deemed eligible. Topline data from the double-blind treatment phase are anticipated in early Q2 2027.

Prime Capital Financial today announced that Emil Ben-David, CFP®, has joined the firm as a wealth advisor.

The Annual Meeting of the HOPE Global Forums, the world’s largest gathering dedicated to economic inclusion, financial literacy and the empowerment of underserved communities, will take place December 2-3, 2026 at the Signia by Hilton in downtown, marking the 12th year that Operation HOPE’s flagship global gathering will be held in Atlanta.

Fasikl, a trailblazing neuro-AI company redefining the intersection of advanced bioelectronic medicine and artificial intelligence (AI), today announced that patients with essential tremor (ET) who used the Felix NeuroAI™ Wristband saw clinically meaningful and sustained functional improvement over a full year, with greater improvement the longer they used it, according to new peer-reviewed data published in Movement Disorder Clinical Practice.1 Another recent article in the same publication established clinically meaningful change thresholds for two commonly used Essential Tremor Rating Assessment Scale (TETRAS)-based outcome measures in ET.2

o9 Solutions, a leading software company that is powering enterprise planning and decisioning models across 30-plus industry verticals with its groundbreaking, AI-powered Digital Brain platform, today announced that it has been named a Leader in the IDC MarketScape: Worldwide Retail Merchandise Financial Planning Solutions 2026 Vendor Assessment (Doc #US54125926, September 2026).

McGraw Hill, Inc. (NYSE: MH; “McGraw Hill” or the “Company”), a leading global provider of education solutions for preK-12, higher education and professional learning, will report fiscal second quarter financial results for the period ended September 30, 2026 on Thursday, November 5, 2026.

Lumentum Holdings Inc. ("Lumentum") today announced that it will release its fiscal first quarter 2027 financial results on Thursday, November 5th, 2026, after the market closes.

The Secured Finance Network (SFNet) Member Directors have elected the FY27 SFNet Management Committee and Executive Committee members, with approval from the Executive Committee. The Secured Finance Foundation (SFFound) Member Donors have also elected the FY27 SFFound Board and Officers, with approval from the SFFound Board.

Gallup and The Rippel Foundation today released Thriving Together in America: Trends, Discoveries, Community Action, and Advice for Leaders, a new report that draws on Gallup's national well-being data with insights from community practitioners working to reverse the decline. The research finds that American well-being has fallen to near historic lows, while hope — Americans’ confidence that their future will be better — has reached its lowest point since Gallup began tracking it in 2008. The report also finds this decline is not inevitable: communities across the country are already using well-being data to understand local conditions, bring residents and leaders together around shared challenges, and change the trajectory.

BioCentury is pleased to announce that registration is now open for the sixth edition of BioCentury Grand Rounds, taking place April 12–14, 2027, in Houston, Texas. The conference convenes academic innovators, biotech founders, biopharma leaders, and investors to bridge the gap between early-stage science and breakthrough new medicines. Registration, scientific poster nominations, and Presenting Company applications are now open.

I2Pure Corp., a biotechnology company specializing in patented molecular iodine (I₂) technology for antimicrobial and antiseptic applications, today announced three recent additions to its team. Based in the company’s Asheville, NC manufacturing facility, Christopher Wilkes joins as Vice President of Production & Supply Chain and Nichole Coggins joins as Director, Quality Engineering. Based at the company’s Manassas, VA R&D lab, Maggie Engert joins as Biomaterials Scientist. Read more about Christopher, Nichole and Maggie (https://i2pure.com/PR-I2Pure-Staff-Expansion-Bios.shtml).

Fifth Third Bancorp (NYSE: FITB) has been named to the 2027 Forbes Best Customer Service list, marking the fourth consecutive year the Bank has earned a place on the annual ranking. The recognition reflects Fifth Third's ongoing commitment to delivering exceptional customer experiences through personalized service, innovative banking solutions and trusted financial guidance.

XTEND AI Robotics, Inc. (NYSE: XTND), a leader in software systems and Physical AI, today announced that the United States Patent and Trademark Office has granted U.S. Utility Patent No. 12,743,960, covering a system in which a smart payload can give XTEND's platform real-time instructions on how to navigate and behave in the field.

Stellar Cyber, the AI-native security operations platform purpose-built for MSSPs and lean enterprise security teams, today announced Stellar Cyber 7.0, a milestone release that advances the Human-Augmented Autonomous SOC from a vision for applying AI to security operations into a practical operating model for running them.

Rodent activity is shifting across the country, with Detroit entering Terminix’s Top 10 for the first time, according to new data from Terminix®, a Rentokil Terminix company. Based on 2025 service data from more than 300 Rentokil-owned Terminix branches nationwide, where residents most frequently used rodent control services in 2025, the company’s annual list of the Top 50 Most Rodent-Infested Cities, reveals notable movement across the country. Five new cities entered the ranking, Milwaukee broke into the Top 20, and San Diego dropped 15 spots.

The Board of Directors (the “Board”) of The Korea Fund, Inc. (NYSE: KF) (the “Fund”) has appointed Canaccord Genuity LLC, (the “Program Manager”) to serve as its agent and broker for purposes of implementing the Fund’s Discount Management Program (the “Program”), with effect as of October 5, 2026.

Datavant, the data collaboration platform trusted for healthcare, today announced the availability of a new identity verification integration with ID.me, the next-generation digital identity wallet simplifying how individuals securely prove their identity online. The integration with Datavant’s Patient Request Tool is designed to help patients request their medical records faster and more easily via secure, simple digital credentials.

Bojangles is turning up the spooky this season, transforming once again into Boojangles, with restaurants embracing the Boojangles look through Halloween-themed restaurant wraps and in-store decor. And this year, the “Scarolina Legend” comes with something new to sink your teeth into: the Bite Box.

Catalent, Inc., the leading global contract development and manufacturing organization (CDMO) dedicated to helping people live better and healthier lives, today announced the U.S. launch of an accelerated gene-to-drug substance program for complex biologics, designed to help developers move bispecifics, multispecifics and other next-generation molecules from gene sequence to drug substance in 10 months. The program builds on Catalent's Rapid Antibody offering for traditional mAbs, which supports gene-to-GMP drug substance in as little as 8 months.

U.S. shoppers are turning to gift cards to keep holiday gifting within budget, while using loyalty points and promotions to make their available spending power go further. At the same time, AI is beginning to influence where that spending goes, according to new research from Blackhawk Network (BHN), a global branded payments provider.

Epicrispr Biotechnologies, a clinical-stage company pioneering epigenetic therapies, today announced updated six-month clinical data from the ongoing open-label, first-in-human Phase 1/2 study evaluating EPI-321 in patients with facioscapulohumeral muscular dystrophy (FSHD). This updated data from the first six patients enrolled in the study were presented at the 31st Annual Congress of the World Muscle Society (WMS 2026) in Hiroshima, Japan.

Evercore announced today that Hans Vestberg has joined the firm as a senior advisor, based in New York.

Wells Fargo & Company (NYSE: WFC), as previously announced, will report its third quarter 2026 earnings results on Tuesday, Oct. 13, 2026, at approximately 7:00 a.m. Eastern time. The results will be available online on our Investor Relations webpage. In addition to being available on the company’s Investor Relations website, the earnings results also will be available on the Securities and Exchange Commission website.

Ryan, a leading global tax services and software provider, is pleased to announce the acquisition of Comtax, a São Paulo-based tax technology and consulting firm specializing in tax determination, tax compliance, and technology-enabled tax operations. The acquisition establishes Ryan’s presence in Brazil and expands the Firm’s ability to help clients manage the country’s demanding tax, compliance, and technology requirements with enhanced accuracy, control, and efficiency.

Northern Trust Wealth Management has appointed Beth Emswiler and Andrew Borner as Senior Managing Directors in the Northeast Region. Emswiler is based in New York, while Borner is based in Greenwich, Connecticut, strengthening the firm’s investment capabilities and client leadership in both markets.

Edgar Matthews & Co. LLC ("Edgar Matthews"), a leading independent investment bank focused on the structured finance ecosystem, today announced that Jamie Showers has joined the firm as a Managing Director and Head of Syndicate & Sales. Mr. Showers will lead Edgar Matthews’ structured products syndicate and institutional investor coverage efforts, with a particular focus on insurance companies and other institutional investors across private structured credit and asset-based finance.

UiPath (NYSE: PATH), a leader in business orchestration and automation, today announced that PLDT, the leading digital services provider in the Philippines, is using a fleet of in-house AI agents built with UiPath Agent Builder™, Integration Service, and Robots to reclaim tens of thousands of hours of manual work annually. Powered by the UiPath Platform™, these agents are deployed across enterprise sales, risk management, and lead generation to eliminate bottlenecks and empower PLDT's workforce.

Toshiba America Business Solutions is accelerating approval and decision processes for growing companies and global brands with the introduction of its Elevate Sky® Workflow UserConnect module.

Upstart Holdings, Inc. (NASDAQ: UPST), the leading artificial intelligence (AI) lending marketplace, today published its monthly origination volume for September 2026 along with the latest Upstart Macro Index (UMI) reading. For historical data and more information, see upstart.com/volume and upstart.com/umi.

Aptar Pharma, a global leader in drug delivery, dosing, protection technologies and services, today announced the launch of Premia™ Precision, a new quality standard for elastomer components, designed to support sensitive and high-value injectable therapies and help pharmaceutical manufacturers advance their quality and regulatory objectives.

Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or the “Company”), a California-based global Embodied AI (EAI) ecosystem company, today shared a weekly business update from YT Jia, Founder and Global CEO of FF.

LTM, the Business Creativity partner to the world's largest enterprises, today announced the launch of BlueVerse™ AgenTraceIQ, an offering designed to help organizations securely adopt and scale agentic AI. Combining Rubrik Agent Cloud with LTM's AI governance and managed services expertise, the offering enables organizations to monitor AI agents, establish guardrails, and rewind unintended agent actions across business-critical environments.

Morningstar, Inc. (Nasdaq: MORN), a leading provider of independent investing insights, today released its annual Morningstar Investors Perspectives Advisor study, the third installment in the 2026 Morningstar Investor Perspectives series. Following research on retail investors and asset owners, the study provides new insight into how advisors are responding to AI adoption, rising client expectations, and market uncertainty. The findings reveal a growing paradox: advisors are embracing AI at pace, but many still feel they lack sufficient time to focus on clients.

Endologix Holdings, LLC today announced Rhevera Medical as its new corporate brand. The new identity reflects the company’s broader commitment to partnering with physicians who treat complex vascular disease and supporting patients whose lives, mobility and independence depend on the company’s technologies.

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its third-quarter financial results on Wednesday, Oct. 28, 2026. The company will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the start of the call.

Krispy Kreme, Inc. (NASDAQ: DNUT) (“Krispy Kreme” or the “Company”) will issue its third quarter 2026 earnings results on Thursday, November 5, 2026. The results and related slide presentation will be available on the Company’s investor relations website at investors.krispykreme.com beginning at approximately 6:45 AM Eastern Time. Management will host a conference call and webcast to discuss the results at 8:00 AM Eastern Time on the same day.

Intercontinental Exchange, Inc. (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets, and home to the largest and most liquid energy derivatives markets in the world, today announced the launch of new tanker and container freight futures and options as average daily volume (ADV) across ICE’s freight markets is up 33% year-to-date.

Distribution Solutions Group, Inc. (NASDAQ: DSGR) (“DSG” or the “Company”), a premier specialty distribution company, today announced that Eclipse Acquisitions Merger Sub, Inc. (“Escrow Issuer”), a newly formed corporation controlled by LKCM Headwater Investments, LLC (“LKCM Headwater” or the “Sponsor”), an affiliate of the Company, plans to offer $700 million aggregate principal amount of Senior Notes due 2032 (the “Notes”), subject to market and other conditions (the “Offering”).

Henkell Freixenet is expanding its premium dealcoholized sparkling wine production capabilities through the deployment of Solos Technology's patented Aroma Recovery System (ARS) at its Wiesbaden production site, the Group’s expertise centre for alcohol-free production. The installation represents a significant investment in next-generation dealcoholized sparkling wine production, helping preserve the natural aroma and sensory identity of the original wines.

Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons and entities who purchased or otherwise acquired Ardelyx, Inc. (NASDAQ: ARDX) common stock between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"). Ardelyx, Inc. develops and commercializes medicines, including IBSRELA for the treatment of irritable bowel syndrome with constipation and XPHOZAH for reducing serum phosphorus in adults with chronic kidney disease on dialysis.

Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, today announced Scott Schaefer, SVP of Finance and Transformation and incoming CFO, will participate in one on one meetings at the Maxim Growth Summit in New York on Wednesday, October 14, 2026.

Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of persons or entities who purchased or otherwise acquired Coastal Financial Corporation (NASDAQ: CCB) common stock between October 28, 2024 and July 29, 2026, inclusive (the “Class Period”). Coastal is a registered bank holding company whose wholly owned subsidiaries include Coastal Community Bank.

Fathom Holdings Inc. (NASDAQ: FTHM) (“Fathom”) and Neighborhood Intelligence, Inc. (NASDAQ: NXH) (“NXH”) today announced that their respective Boards of Directors have mutually agreed to terminate the previously announced merger agreement between the companies.

Summit Therapeutics Inc. (NASDAQ: SMMT) today announced the successful closing of AstraZeneca’s (LSE/STO/NYSE: AZN) strategic equity investment in Summit. The equity investment will support continued acceleration of the development of ivonescimab, a novel, potential first-in-class investigational PD-1 / VEGF bispecific antibody.